Newsroom| Press Releases
View our collection of Press Releases
SAN ANTONIO, January 8, 2019 – Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology...
– Company’s technology, which shows promise as a clinical prognostic tool that may facilitate treatment...
– San Antonio-based technology company focuses on improving breast cancer diagnostic accuracy and ‘walking...
– Publication in ClinicoEconomics and Outcomes Research estimates nearly $8 billion annually in expense...
– Publication in AJR defines advanced statistical methods that can be used with diagnostic imaging output...
-2017 award recognizes a novel optical imaging modality that provides high molecular contrast of
important...
– Prospective clinical study presented at the San Antonio Breast Cancer Symposium suggests Imagio findings...
CHICAGO, November 28, 2017 – Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology...
Results Presented in a High Impact Clinical Trial Session at the Radiology Society of North America (RSNA)...
Imagio® is FDA approved for commercial distribution in the U.S. and ready for your patients. Contact our Sales Department today.
View featured stories in the Seno Medical industry.
View Seno Medical's Media Kit, which includes approved imagery, official logo and more.